Close

View Older Stories View More Recent Stories

Mar 13, 2018 04:30PM Medicines Co. (MDCO) Provides Important Update on Ph 3 RNAi Program - Evercore ISI
Mar 12, 2018 08:41AM ODYSSEY Results Seen as Positive for Medicines Co. (MDCO)
Mar 9, 2018 07:37AM UPDATE: Evercore ISI Starts miRagen Therapeutics (MGEN) at Outperform
Mar 8, 2018 12:33PM Jazz Pharmaceuticals (JAZZ) Xyrem Competitor Delayed - Evecore ISI
Feb 8, 2018 08:32AM Teva Pharma (TEVA) Leaving Room for Upside Surprise in EBITDA Guidance - Evercore ISI
Jan 16, 2018 05:57AM UPDATE: Evercore ISI Starts Dicerna Pharmaceuticals (DRNA) at Outperform; Alnylam Case Appears Favorable
Dec 21, 2017 08:50AM Biogen (BIIB) Defended at Evercore ISI; BAN-2401 Data Should Not Move Stock
Dec 20, 2017 10:19AM Mylan (MYL) Positioned for Possible Late 2019/2010 Launch of Glargine - Evercore ISI (SNY)
Dec 4, 2017 07:47AM Evercore ISI Starts Apellis Pharmaceuticals (APLS) at Outperform
Dec 1, 2017 08:14AM Valeant Pharma (VRX) in 'Very Good Shape' on Debt Covenants - Evercore ISI's Raffat
Nov 22, 2017 10:23AM GSK (GSK) Not Trying to Break Price in HIV with Dulo, Positive for Gilead Sciences (GILD) - Evercore ISI Raffat
Nov 10, 2017 01:15PM Everore ISI's Raffat Provides Takeaways on Juno Therapeutics (JUNO) ROCKET Trial Data (GILD)
Nov 1, 2017 10:34AM Allergan (AGN) Should Be Up - Evercore ISI's Raffat
Oct 25, 2017 11:17AM Teva Pharma (TEVA) Files Lawsuit Versus Eli Lilly (LLY) Related to CGRP Mab - Evercore ISI
Oct 10, 2017 05:19PM Evercore ISI named #3 in U.S. Equity Research by Institutional Investor's All-America Equity Research Survey
Oct 6, 2017 10:41AM UPDATE: Biogen (BIIB), Roche on Watch Amid Potential New PML case on Ocrevus
Sep 22, 2017 08:22AM Too Much 'Confusion and Nervousness' in Allergan (AGN) - Evercore ISI
Sep 21, 2017 03:59PM Express Scripts (ESRX) CMO Issues Blog on CAR-Ts and Gene Therapies
Sep 8, 2017 02:12PM Allergan (AGN) Legal Move 'Extremely Important for Industry' - Evercore ISI Raffat
Aug 9, 2017 09:32AM Evecore ISI's Raffat sees ~$29/sh valuation floor on Mylan (MYL) on the new guidance
Jul 25, 2017 08:00AM Josh Schimmer Joins Evercore ISI Research Team
Jun 29, 2017 04:29PM UPDATE: Evercore ISI Starts Dermira (DERM) at Outperform; Street Underestimating Acne Phase 3 Success
Jun 26, 2017 12:26PM Valeant Pharma (VRX) Gains Tied to Speculation of Debt-for-Equity Swap - Evercore ISI's Raffat
Jun 13, 2017 11:57AM Amgen (AMGN): ICER intends to lower the value-based price benchmark for Repatha - Evercore ISI
May 19, 2017 09:39AM Gilead Sciences (GILD) Called 'Value Pick' at Evercore ISI
May 11, 2017 03:23PM Valeant Pharma (VRX) is Soaring Because of This - Evercore ISI's Raffat
Apr 20, 2017 12:09PM ASCO Abstract Titles Officially Available Online; Evecore ISI's Raffat Highlights a Few
Mar 31, 2017 12:09PM Biogen (BIIB) Wins Interference versus Forward Pharma (FWP) - Evercore ISI
Mar 14, 2017 06:14PM Valeant shares fall as Ackman exit highlights company's challenges
Feb 24, 2017 01:25PM Pharma Stocks on Watch as Draft Obamacare Reform Bill Makes No Mention of Drug Prices - Evercore's Raffatt
Feb 22, 2017 04:19PM Evercore ISI Starts Jazz Pharmaceuticals (JAZZ) at Buy
Feb 3, 2017 08:22AM Impax Laboratories (IPXL) Generic EpiPen Shows 'Meaningful Gains' Versus Mylan's EpiPen - Evercore ISI Raffat
Jan 20, 2017 07:51AM Generics File Against New Teva Pharma (TEVA) Copaxone 40MG Patent - Evercore ISI
Jan 10, 2017 09:49AM Valeant Pharma (VRX): 'Finally Some Good News' - Evecore ISI's Raffat
Jan 3, 2017 07:13AM Allergan (AGN) on Watch After Raising Drug Prices
Dec 29, 2016 01:26PM Allergan (AGN) Sees Sneaky Gains Into Year-End After Disastrous 2016
Dec 13, 2016 11:22AM Allergan (AGN) Has an Important Catalyst Forthcoming that is Flying Under the Radar - Evercore ISI's Raffat
Nov 15, 2016 01:10PM Medicines Co. (MDCO) Recovers; Evercore ISI's Raffat Says Data 'Looks Very Consistent and Durable'
Nov 8, 2016 10:03AM Biggest Takeaway from Valeant (VRX) Call is 2017 Revs and EBITDA Expected to Be Below 2016 - Evecore ISI's Raffat
Nov 8, 2016 07:53AM Valeant Pharma (VRX) EBITDA Was North of $1B, Which Was Better than Feared - Evecore ISI Raffat
Nov 2, 2016 06:56AM Allergan CEO takes blame for big miss on quarterly earnings
Oct 6, 2016 04:45PM Evercore ISI named # 3 in U.S. Equity Research by Institutional Investor's All-America Equity Research Survey
Sep 29, 2016 12:01PM Valeant Pharma (VRX), Other Pharma Stocks Weaker as Clinton Op-Ed Discusses Measures on Drug Prices
Sep 29, 2016 11:50AM Allergan (AGN) Namenda Concerns 'Not a Big Deal' - Evecore ISI's Raffat
Sep 28, 2016 10:33AM Evercore ISI Raffat Highlights New Development on Teva Pharma (TEVA) from Copaxone Hearing
Sep 14, 2016 09:46AM Mylan CEO to testify before House panel over EpiPen pricing
Sep 7, 2016 11:24AM 1997 CMS Letter to Mylan (MYL) Shows Evidence of EpiPen Medicaid Rebate - Evecore ISI's Raffat
Aug 29, 2016 07:45AM Evercore ISI Starts Theravance Biopharma (TBPH) at Buy
Aug 26, 2016 07:47AM Why All the Outcry About EpiPen Prices Now? It's Back to School Time
Aug 25, 2016 11:46AM Mylan's (MYL) EpiPen Saga Could Add More Supply Chain Volatility Moving Forward - Evercore
View More Recent Stories View Older Stories